Baker Norton Pharmaceuticals, Inc.
Records under this name other than patents Baker Norton Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Baker Norton Pharmaceuticals, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,235,725 | Methods and compositions for the prevention of tolerance to medications Formerly held Term ended Term ended Jul 28, 2019 · USPTO record | Term ended | Term ended Jul 28, 2019 | USPTO record |
| US 6,193,957 | Pharmaceutical compositions for treating late phase allergic reactions and inflammatory diseases Formerly held Term ended Term ended May 4, 2019 · USPTO record | Term ended | Term ended May 4, 2019 | USPTO record |
| US 6,290,930 | Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide Term ended Term ended Dec 18, 2018 · USPTO record | Term ended | Term ended Dec 18, 2018 | USPTO record |
| US 6,030,113 | Mixing apparatus and method for mixing black liquor from cellulose production with ash from flue gases formed from combustion of black liquor Formerly held Term ended Term ended Jul 10, 2018 · USPTO record | Term ended | Term ended Jul 10, 2018 | USPTO record |
| US 7,056,898 | Hypersulfated disaccharides and methods of using the same for the treatment of inflammations Formerly held Lapsed on the fee record Ended Jun 6, 2018 · USPTO record | Lapsed on the fee record | Ended Jun 6, 2018 | USPTO record |
| US D439,325 | Cover for a nasal inhaler Formerly held Term ended Term ended Mar 20, 2015 · USPTO record | Term ended | Term ended Mar 20, 2015 | USPTO record |
| US 6,395,770 | Method and compositions for administering taxanes orally to human patients Lapsed on the fee record Ended May 28, 2014 · USPTO record | Lapsed on the fee record | Ended May 28, 2014 | USPTO record |
| US 7,041,640 | Method, compositions and kits for increasing the oral bioavailability of pharmaceutical agents Lapsed on the fee record Ended May 9, 2014 · USPTO record | Lapsed on the fee record | Ended May 9, 2014 | USPTO record |
| US 6,964,946 | Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same Lapsed on the fee record Ended Nov 15, 2013 · USPTO record | Lapsed on the fee record | Ended Nov 15, 2013 | USPTO record |
| US 6,936,583 | Method and compositions for administering taxanes orally to human patients Lapsed on the fee record Ended Aug 30, 2013 · USPTO record | Lapsed on the fee record | Ended Aug 30, 2013 | USPTO record |